Piloto

i am out. cash cash cash . no more traps

ready yo enter at 0.07?

i am still in and i am not fucking selling . it is very clear to me that this is the right vaccine stock to be in. patiently waiting to ride with the big guys movers. it will be surprising crazy!

Insiders only sold the extra shares the own after buying the bunch of 10MM at $10.00 . They only need to have the allowed quantity by law that is why they have to sell some at higher price .

Glad this is up but just an advise . I lost a lot of money premarket . Cash when you can and wait for a very good solid news. They pump it and then drop it like dead

Partnership deal going on. Big pharma jumping to help in manufacturing . That is why all these lately sales.

Have you heard the news in India . This stock will be unreachable in price by tomorrow 7:00 am

Just came in the India news :

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

Rupali Mukherjee / TNN / May 4, 2021, 02:18 IST

MUMBAI: The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July.
While Serum Institute is to supply 11 crore doses of Covishield, the rest will be Covaxin manufactured by Bharat Biotech. Based on the advance paid on April 28, the price works out to a little under Rs 160 per shot.
SII CEO Adar Poonawalla had suggested that the Centre should increase the price as the company needed to boost capacity.
The government’s statement came after Poonawalla’s interview to The Financial Times, where he had suggested the company did not expand capacity due to the absence of orders. Besides, the Centre has been facing criticism for not procuring enough vaccine before opening inoculations for those over 18 years.
It said that against an earlier order of 10 crore doses, Serum had delivered 8.7 crore shots till Monday, while Bharat Biotech had delivered 88 lakh against an order of 2 crore shots. The Centre had announced last month that it is making an advance payment of around Rs 3,000 crore to Serum Institute and Rs 1,500 crore to Bharat Biotech.
The controversy also forced Poonawalla to issue a statement, saying the firm has been working closely with the government for the past year and is committed to ramping up capacity. “...it is not possible to ramp up production overnight. We also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations,” he said, adding he would like to clarify since his (overall) comments may have been misinterpreted.
Poonawalla said against overall orders of over 26 crore doses, Rs 15 crore had been supplied to the government. “Another 11 crore doses will be supplied in the second channel for state and private hospitals,” he said.

Just came in

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

Rupali Mukherjee / TNN / May 4, 2021, 02:18 IST

MUMBAI: The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July.
While Serum Institute is to supply 11 crore doses of Covishield, the rest will be Covaxin manufactured by Bharat Biotech. Based on the advance paid on April 28, the price works out to a little under Rs 160 per shot.
SII CEO Adar Poonawalla had suggested that the Centre should increase the price as the company needed to boost capacity.
The government’s statement came after Poonawalla’s interview to The Financial Times, where he had suggested the company did not expand capacity due to the absence of orders. Besides, the Centre has been facing criticism for not procuring enough vaccine before opening inoculations for those over 18 years.
It said that against an earlier order of 10 crore doses, Serum had delivered 8.7 crore shots till Monday, while Bharat Biotech had delivered 88 lakh against an order of 2 crore shots. The Centre had announced last month that it is making an advance payment of around Rs 3,000 crore to Serum Institute and Rs 1,500 crore to Bharat Biotech.
The controversy also forced Poonawalla to issue a statement, saying the firm has been working closely with the government for the past year and is committed to ramping up capacity. “...it is not possible to ramp up production overnight. We also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations,” he said, adding he would like to clarify since his (overall) comments may have been misinterpreted.
Poonawalla said against overall orders of over 26 crore doses, Rs 15 crore had been supplied to the government. “Another 11 crore doses will be supplied in the second channel for state and private hospitals,” he said.

Just came in :

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

Rupali Mukherjee / TNN / May 4, 2021, 02:18 IST

MUMBAI: The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July.
While Serum Institute is to supply 11 crore doses of Covishield, the rest will be Covaxin manufactured by Bharat Biotech. Based on the advance paid on April 28, the price works out to a little under Rs 160 per shot.
SII CEO Adar Poonawalla had suggested that the Centre should increase the price as the company needed to boost capacity.
The government’s statement came after Poonawalla’s interview to The Financial Times, where he had suggested the company did not expand capacity due to the absence of orders. Besides, the Centre has been facing criticism for not procuring enough vaccine before opening inoculations for those over 18 years.
It said that against an earlier order of 10 crore doses, Serum had delivered 8.7 crore shots till Monday, while Bharat Biotech had delivered 88 lakh against an order of 2 crore shots. The Centre had announced last month that it is making an advance payment of around Rs 3,000 crore to Serum Institute and Rs 1,500 crore to Bharat Biotech.
The controversy also forced Poonawalla to issue a statement, saying the firm has been working closely with the government for the past year and is committed to ramping up capacity. “...it is not possible to ramp up production overnight. We also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations,” he said, adding he would like to clarify since his (overall) comments may have been misinterpreted.
Poonawalla said against overall orders of over 26 crore doses, Rs 15 crore had been supplied to the government. “Another 11 crore doses will be supplied in the second channel for state and private hospitals,” he said.